MFMax Field

Max Field

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Max Field has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • A. Cook

    Centre for Rheumatic Diseases, University of Glasgow Department of Medicine, Queen Elizabeth Building, Glasgow Royal Infirmary, Glasgow G31 2ER, Scotland, United Kinddom Tel.: (0044) 141 211 4687/8 Fax: (0044) 141 211 4878

    1 shared publication
  • David M Lloyd

    Medical Education Department, University of Glasgow Medical School, University of Glasgow, Glasgow, UK

    1 shared publication
  • David McAllister

    Medical Education Department, University of Glasgow Medical School, University of Glasgow, Glasgow, UK

    1 shared publication
  • G. Gallagher

    University of Glasgow Department of Surgery, Queen Elizabeth Building, Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom

    1 shared publication
  • Joanne M Burke

    Medical Education Department, University of Glasgow Medical School, University of Glasgow, Glasgow, UK

    1 shared publication
  • M N Gupta

    Centre for Rheumatic Diseases, University Department of Medicine, Glasgow Royal Infirmary, Scotland, UK

    1 shared publication

Latest Publications

  • Peer‐assisted learning: a novel approach to clinical skills learning for medical students

    by Max Field, Joanne M Burke, David McAllister, David M Lloyd

    Objective  This study aimed to determine whether peer‐assisted learning (PAL) can enhance clinical examination skills training. Methods  Three student trainers studied small‐group theory and clinical examination and provided PAL as extra tuition for 86 trainees. Trainees watched an examination video, were videotaped practising the examination and, after constructive feedback, repeated the examination. Responses to PAL were evaluated to attain an overview of trainee and trainer performance using visual analogue and Likert scale analyses. Year‐group review was undertaken using questionnaires. Results  Trainees evaluated all aspects of PAL highly, including their post‐training confidence in examination skills (mean > 7.7 on a 10‐cm scale), indicating that the PAL was effective. Written comments confirmed the students perceived the sessions as well structured and of high quality. Compared with trainees in the first groups, those from later groups gave all parameters similar or higher gradings. Those for interest ( P = 0.03) and appropriateness ( P = 0.01) were significantly higher, suggesting that trainers may improve their technique with time. Students with previous degrees gave similar or lower gradings than standard entry students, with answers about post‐training confidence and recommendation to friends being statistically lower ( P < 0.006). Six months later, year‐group analysis showed that 90% of trainees rated PAL highly, and 86% wished to become trainers. Of the trainers' year group, 79% perceived that PAL training could improve examination skills. Conclusions  In the context of clinical skills training, PAL was highly evaluated across many parameters, including confidence after training. Student interest and enthusiasm supports suggestions that PAL could be a useful adjunct to clinical skills training.


  • Open Access

    Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritis

    by M N Gupta, R D Sturrock, M Field

    Objective: To investigate whether patients with acute septic arthritis (SA) diagnosed by positive synovial fluid (SF) culture (Newman grade A) have different clinical and serological features from those with sterile SF in whom there is nonetheless a high suspicion of SA (Newman grades B and C). Patients and methods: A prospective 12 month multicentre hospital based study of adult patients with SA recruited 47 patients with culture positive SA and 35 patients with clinically suspected SA but sterile SF. Results: Patient demography, clinical and laboratory features at presentation were similar irrespective of the underlying diagnosis, SF culture, and the presence of prosthetic joints. Medical and surgical treatment and outcome were comparable in the two patient groups. Patients with both suspected and proven SA were more likely to be from the more socially deprived areas of our community (pConclusion: Patients in whom there is a high clinical suspicion of SA are comparable to those patients with SA with a positive SF culture and have similar morbidity and mortality on follow up. Therefore, if clinical suspicion of SA is high then it is correct to treat as SA in the absence of bacterial proof.


  • Open Access

    Tumour necrosis factor polymorphisms in rheumatic diseases

    by M. Field

    Tumour necrosis factor α (TNFα) is a pro‐inflammatory cytokine that plays a key role in the pathogenesis of many infections and inflammatory diseases. 1 It was identified through its ability to lyse tumour cells,2 but in retrospect this ability was first noted nearly 100 years ago, when Coley's toxins were shown to destroy sarcoma cells. TNFα is now recognized to be involved in stimulation of cytokine production, enhancing expression of adhesion molecules and neutrophil activation, and it is also a co‐stimulator for T‐cell activation and antibody production by B cells. 1 As such, it contributes to the regulation of normal homeostasis, as well as playing an important role in inflammation.


  • Immuno-localisation of tumour necrosis factor and its receptors in temporal arteritis

    by M. Field, A. Cook, G. Gallagher

    Temporal arteritis (TA) is an acute vasculitis characterised by destruction of arterial architecture following infiltration of the arterial wall by macrophages, giant cells and lymphocytes. Using immunohistochemical techniques, tumour necrosis factor (TNF) was demonstrated in up to 60% of the cells in all areas of inflamed arteries. More cells staining for TNF were detected in the intima and media of inflamed vessels than control uninflamed arteries (PP<0.001, respectively). In TA, TNF was localised to giant cells and macrophages, suggesting that its predominant source is from the monocyte lineage, but, occasionally, TNF staining was found in areas infiltrated by T cells. Many endothelial cells also contained TNF, but there were no differencs between the number of endothelial cells staining in inflamed and normal blood vessels. Of the two TNF receptors, the p75 receptor was sparsely represented in the inflamed vessels in TA. By comparison, the p55 receptor was widely detected on endothelial cells and infiltrating mononuclear cells close to the internal elastic lamina (IEL). Endothelial cells from normal vessels also stained for both TNF receptors, but normal smooth muscle cells in the vessel media expressed the p55 receptor, indicating that they are capable of responding to locally secreted TNF. Localisation of TNF receptors and TNF in close proximity to the IEL suggests that TNF could be involved in the leucocyte infiltration and arterial wall destruction characteristic of TA.